111 Capital’s Silicon Laboratories SLAB Stock Holding History

111 Capital’s Portfolio SLAB Stock Details SLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,758	Closed	-$231K	–	513
2025 Q3	$231K	Buy	+1,758	New	+$239K	0.04%	380

Other funds holding SLAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

111 Capital's SLAB Position: Q4 2025 in Review

111 Capital sold out of Silicon Laboratories (SLAB) in Q4 2025, closing a stake of 1,758 shares — an estimated $231K sold.

111 Capital first reported a position in SLAB in Q3 2025 and held it in 1 quarter. The position peaked at $231K in Q3 2025. 326 funds tracked by Wall St. Rank hold SLAB as of Q4 2025.

111 Capital reported no remaining Silicon Laboratories position as of Q4 2025 after selling out during the quarter.
111 Capital sold 1,758 Silicon Laboratories shares in Q4 2025, an estimated $231K.
111 Capital first reported a position in Silicon Laboratories in Q3 2025 and held it in 1 quarter.
111 Capital's Silicon Laboratories position peaked at $231K in Q3 2025.
326 funds tracked by Wall St. Rank held Silicon Laboratories as of Q4 2025.

Based on 111 Capital's 13F filing for Q4 2025, filed 11 Feb 2026.